450 related articles for article (PubMed ID: 27437104)
1. B cell regulation of the anti-tumor response and role in carcinogenesis.
Schwartz M; Zhang Y; Rosenblatt JD
J Immunother Cancer; 2016; 4():40. PubMed ID: 27437104
[TBL] [Abstract][Full Text] [Related]
2. Regulatory B cells in anti-tumor immunity.
Zhang Y; Gallastegui N; Rosenblatt JD
Int Immunol; 2015 Oct; 27(10):521-30. PubMed ID: 25999597
[TBL] [Abstract][Full Text] [Related]
3. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
4. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
5. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
6. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma.
Bao J; Betzler AC; Hess J; Brunner C
Front Immunol; 2023; 14():1233085. PubMed ID: 37868967
[TBL] [Abstract][Full Text] [Related]
7. Immune response regulation in the tumor microenvironment by hypoxia.
Labiano S; Palazon A; Melero I
Semin Oncol; 2015 Jun; 42(3):378-86. PubMed ID: 25965356
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
9. Control of NK cell functions by CD4+CD25+ regulatory T cells.
Ralainirina N; Poli A; Michel T; Poos L; Andrès E; Hentges F; Zimmer J
J Leukoc Biol; 2007 Jan; 81(1):144-53. PubMed ID: 16959895
[TBL] [Abstract][Full Text] [Related]
10. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
Guo Z; Wang H; Meng F; Li J; Zhang S
J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.
Lindner S; Dahlke K; Sontheimer K; Hagn M; Kaltenmeier C; Barth TF; Beyer T; Reister F; Fabricius D; Lotfi R; Lunov O; Nienhaus GU; Simmet T; Kreienberg R; Möller P; Schrezenmeier H; Jahrsdörfer B
Cancer Res; 2013 Apr; 73(8):2468-79. PubMed ID: 23384943
[TBL] [Abstract][Full Text] [Related]
12. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
Zhou H; Chen L; You Y; Zou L; Zou P
Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
14. Methyl gallate exhibits potent antitumor activities by inhibiting tumor infiltration of CD4+CD25+ regulatory T cells.
Lee H; Lee H; Kwon Y; Lee JH; Kim J; Shin MK; Kim SH; Bae H
J Immunol; 2010 Dec; 185(11):6698-705. PubMed ID: 21048105
[TBL] [Abstract][Full Text] [Related]
15. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
17. Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.
Teng MW; Swann JB; von Scheidt B; Sharkey J; Zerafa N; McLaughlin N; Yamaguchi T; Sakaguchi S; Darcy PK; Smyth MJ
Cancer Res; 2010 Apr; 70(7):2665-74. PubMed ID: 20332236
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
Tsukamoto H; Nishikata R; Senju S; Nishimura Y
Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]